Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02119117
Other study ID # REACh-002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2014
Est. completion date May 2018

Study information

Verified date May 2018
Source Reproductive Endocrinology Associates of Charlotte
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pregnancy rates for women over 35 years old are significantly lower when compared to younger women. One of the causes for this decrease is believed to be chromosomal aneuploidy. Chromosomal aneuploidy is a natural phenomena and occurs in women of every age and has been implicated in spontaneous miscarriages, and preimplantation embryo wastage (Hassold and Hunt, 2001).

As maternal age increases, so too does the incidence of chromosomal aneuploidy. Embryo quality from older patients undergoing IVF tends to be reduced and associated with higher rates of chromosomal abnormalities when compared to good quality embryos (Munne et al., 1995).

Chromosomal aneuploidy derives from the improper segregation of chromosomes during preimplantation development. The process of segregation, or mitosis, includes synthesis of the complete genome, equal division of chromosomes to opposite poles by the spindle apparatus, and separation of the two cells by cytokinesis, yielding two chromosomally identical cells. The entire process of cellular and genetic replication requires energy in the form of adenosine tri phosphate (ATP). ATP is mainly produced in mitochondria in the process known as the electron transport chain (ETC). There are many important molecules required for ATP production, CoQ10 can act as the appropriate carrier of electrons through the ETC. When a deficiency in CoQ10 is present, ATP production is decreased resulting in aneuploidy (Bentov et al., 2013). Similarly, research has shown that chromosome alignment and spindle formation are affected by mtDNA copy number (Ge et al., 2012). It has also been shown that the transfer of ooplasm from young, healthy oocyte donors into oocytes of women with repeated embryonic failure has result in children with subsequent mitochondrial heteroplasmy (Cohen et al., 1998).

CoQ10 concentrations have been shown to decrease as age increases (Bentov et al., 2011). Consequently, the decrease in CoQ10 concentrations seen in older women may cause an increase in chromosomal aneuploidy in subsequent embryos (Bentov et al., 2013). In this pilot study, we test the hypothesis that the supplementation of CoQ10 prior to an IVF cycle can increase mitochondrial DNA activity and possibly decrease chromosomal aneuploidy in AMA patients.


Description:

Brief Summary


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date May 2018
Est. primary completion date May 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 36 Years to 42 Years
Eligibility Inclusion Criteria:

1. 36-42 years old

2. Must present with an AMH level =2.0 ng/mL

3. 1st cycle of IVF treatment

4. Antral follicle count >5 and <20

Exclusion Criteria:

1. BMI >39

2. Active smoker

3. Blood serum baseline level of CoQ10 =2.20 µg/mL

4. Prior use of CoQ10

5. Type II diabetes mellitus

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
CoQ10
This is a dietary supplement which will be administered daily to the patient for 3 months prior to IVF
Placebo
This is a placebo which will be administered daily to the patient for 3 months prior to IVF.

Locations

Country Name City State
United States REACh Charlotte North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Reproductive Endocrinology Associates of Charlotte

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Embryo mitochondrial DNA (mtDNA) mtDNA levels will be assesed from day 5 or day 6 blastocysts
Secondary preimplantation chromosomal aneuploidy aneuploidy rates will be measured utilizing SNP array from day 5 and day 6 blastocysts
See also
  Status Clinical Trial Phase
Completed NCT03673592 - Clinical Value of Mosaicism Diagnosis on the Trophectoderm Biopsies
Completed NCT02268786 - Single Embryo TrAnsfeR of Euploid Embryo N/A
Completed NCT01574404 - Polar Body Biopsy for Preimplantation Genetic Screening N/A
Not yet recruiting NCT03981120 - The Effect of Acupuncture on Pregnancy Rates in Women Undergoing in Vitro Fertilization With Preimplantation Genetic Screening N/A
Recruiting NCT05545995 - Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection
Recruiting NCT05547555 - Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection
Completed NCT02787486 - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Active, not recruiting NCT04865367 - How Secreted-embryo-derived Trypsin Initiates, Maintains and Terminates Ca2+ Signals in Uterine Epithelial Cells
Completed NCT01052688 - Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
Completed NCT03816423 - Use of Videos to Improve Patient Knowledge on Prenatal Genetics N/A
Recruiting NCT03449225 - Prenatal Computer-Aided Genetics Education Module N/A
Completed NCT03860064 - Aneuploidy Rates of in Vitro Matured Oocytes
Recruiting NCT04000152 - RCT Study to Validate niPGT-A Clinical Benefit. N/A
Recruiting NCT06419127 - Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing
Active, not recruiting NCT04901247 - A Time-lapse Monitoring Prospective Study
Active, not recruiting NCT05492981 - Does an Educational Video for Aneuploidy Screening Improve Informed Choice Among Pregnant Women? N/A
Completed NCT04420858 - Effect of Video Education on Patients' Knowledge and Attitudes of Privacy in Prenatal Genetics N/A
Completed NCT01597063 - Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies N/A
Completed NCT02284399 - National Prevalence and Impact of Noninvasive Prenatal Testing
Terminated NCT01545674 - Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial